The effect of FTY720 in the Theiler's virus model of multiple sclerosis

Journal of the Neurological Sciences

Volumn 308, Issue 1-2, 2011, Pages 41-48

  Li, Libin ^a   Matsumoto, Makiko ^a   Seabrook, Timothy J ^b,c   Cojean, Celine ^b   Brinkman, Volker ^b   Pachner, Andrew R ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MERCK SERONO S A   (Switzerland)

Author keywords

Animal model; Antibody responses; FTY720; Multiple sclerosis; Progressive disability; TMEV

Indexed keywords

FINGOLIMOD; IMMUNOGLOBULIN G;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD; CELL COUNT; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; DRUG EFFECT; FEMALE; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MICE; MULTIPLE SCLEROSIS; PROPYLENE GLYCOLS; SPHINGOSINE; THEILOVIRUS; VIRAL LOAD;

EID: 80051591091     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.06.029     Document Type: Article

References (38)

1. J.A. Cohen, F. Barkhof, G. Comi, H.P. Hartung, B.O. Khatri, and X. Montalban Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N Engl J Med 362 2010 402 415
2. L. Kappos, E.W. Radue, P. O'Connor, C. Polman, R. Hohlfeld, and P. Calabresi A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 2010 387 401
3. V. Brinkmann, M.D. Davis, C.E. Heise, R. Albert, S. Cottens, and R. Hof The immune modulator FTY720 targets sphingosine 1-phosphate receptors J Biol Chem 277 2002 21453 21457
4. T.H. Pham, T. Okada, M. Matloubian, C.G. Lo, and J.G. Cyster S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress Immunity 28 2008 122 133
5. M. Mehling, V. Brinkmann, J. Antel, A. Bar-Or, N. Goebels, and C. Vedrine FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis Neurology 71 2008 1261 1267
6. C.A. Foster, L.M. Howard, A. Schweitzer, E. Persohn, P.C. Hiestand, and B. Balatoni Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis J Pharmacol Exp Ther 323 2007 469 475
7. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, and G. Francis Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat Rev Drug Discov 9 2010 1
8. V.E. Miron, J.A. Hall, T.E. Kennedy, B. Soliven, and J.P. Antel Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod Am J Pathol 173 2008 1143 1152
9. M.C. Dal Canto, and H.L. Lipton Multiple sclerosis. Animal model: Theiler's virus infection in mice Am J Pathol 88 1977 497 500
10. D.B. McGavern, L. Zoecklein, K.M. Drescher, and M. Rodriguez Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination Exp Neurol 158 1999 171 181
11. L.J. Zoecklein, K.D. Pavelko, J. Gamez, L. Papke, D.B. McGavern, and D.R. Ure Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus Brain Pathol 13 2003 291 308
12. D.D. Pinschewer, A.F. Ochsenbein, B. Odermatt, V. Brinkmann, H. Hengartner, and R.M. Zinkernagel FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory J Immunol 164 2000 5761 5770
13. M. Webb, C.S. Tham, F.F. Lin, K. Lariosa-Willingham, N. Yu, and J. Hale Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice J Neuroimmunol 153 2004 108 121
14. H. Kataoka, K. Sugahara, K. Shimano, K. Teshima, M. Koyama, and A. Fukunari FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration Cell Mol Immunol 2 2005 439 448
15. M. Trottier, P. Kallio, W. Wang, and H.L. Lipton High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus J Virol 75 2001 7420 7428
16. L. Li, K. Narayan, E. Pak, and A.R. Pachner Intrathecal antibody production in a mouse model of Lyme neuroborreliosis J Neuroimmunol 173 2006 56 68
17. A.R. Pachner, J. Brady, and K. Narayan Antibody-secreting cells in the central nervous system in an animal model of MS: phenotype, association with disability, and in vitro production of antibody J Neuroimmunol 190 2007 112 120
18. A.R. Pachner, L. Li, and K. Narayan Intrathecal antibody production in an animal model of multiple sclerosis J Neuroimmunol 185 2007 57 63
19. S.I. Tschen, C.C. Bergmann, C. Ramakrishna, S. Morales, R. Atkinson, and S.A. Stohlman Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis J Immunol 168 2002 2922 2929
20. H.L. Lipton, and F. Gonzalez-Scarano Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response J Infect Dis 137 1978 145 151
21. A.R. Pachner An improved ELISA for screening for neutralizing anti-IFN-beta antibodies in MS patients Neurology 61 2003 1444 1446
22. K. Narayan, D. Dail, L. Li, D. Cadavid, S. Amrute, and P. Fitzgerald-Bocarsly The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis Ann Neurol 57 2005 813 823
23. C.I. Kurtz, X.M. Sun, and R.S. Fujinami Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus Microb Pathog 18 1995 11 27
24. M. Trottier, B.P. Schlitt, A.Y. Kung, and H.L. Lipton Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease J Virol 78 2004 12480 12488
25. M. Mehling, R. Lindberg, F. Raulf, J. Kuhle, C. Hess, and L. Kappos Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis Neurology 75 2010 403 410
26. B.S. Kim, M.A. Lyman, B.S. Kang, H.K. Kang, H.G. Lee, and M. Mohindru Pathogenesis of virus-induced immune-mediated demyelination Immunol Res 24 2001 121 130
27. M. Rodriguez Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis Brain Pathol 17 2007 219 229
28. H.L. Lipton, and M.C. Dal Canto Theiler's virus-induced demyelination: prevention by immunosuppression Science 192 1976 62 64
29. C.S. Tan, and I.J. Koralnik Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis Lancet Neurol 9 2010 425 437
30. C.A. Foster, D. Mechtcheriakova, M.K. Storch, B. Balatoni, L.M. Howard, and F. Bornancin FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage Brain Pathol 19 2009 254 266
31. B. Balatoni, M.K. Storch, E.M. Swoboda, V. Schönborn, A. Koziel, and G.N. Lambrou FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis Brain Res Bull 74 2007 307 316
32. M. Fujino, N. Funeshima, Y. Kitazawa, H. Kimura, H. Amemiya, and S. Suzuki Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment J Pharmacol Exp Ther 305 2003 70 77
33. E. Meinl, M. Krumbholz, and R. Hohlfeld B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation Ann Neurol 59 2006 880 892
34. A.R. Pachner, L. Li, and D. Lagunoff Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis J Neuroimmunol 232 1-2 2011 Mar 35 40
35. K.A. Fairfax, A. Kallies, S.L. Nutt, and D.M. Tarlinton Plasma cell development: from B-cell subsets to long-term survival niches Semin Immunol 20 2008 49 58
36. E.J. McMahon, S.L. Bailey, C.V. Castenada, H. Waldner, and S.D. Miller Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis Nat Med 11 2005 335 339
37. T. Matsushita, K. Yanaba, J.D. Bouaziz, M. Fujimoto, and T.F. Tedder Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression J Clin Invest 118 2008 3420 3430
38. H.L. Lipton, and C.D. Canto Contrasting effects of immunosuppression on Theiler's virus infection in mice Infect Immun 15 1977 903 909